Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 6, 2026

Total Value: $313M (100.0% shares, 0.0% debt)

Holdings (39)

LLY Eli Lilly & Co 10.7%
Value $33.46M Shares 31,133 Est. Cost $707.31 Unrealized +35.1%
ABBV AbbVie Inc 7.9%
Value $24.72M Shares 108,181 Est. Cost $176.08 Unrealized +29.2%
MRK Merck & Co. Inc 6.6%
Value $20.61M Shares 195,768 Est. Cost $98.68 Unrealized -5.5%
TMO Thermo Fisher Scientific Corp 5.5%
Value $17.33M Shares 29,915 Est. Cost $519.30 Unrealized +8.8%
NBIX Neurocrine Biosciences Inc 4.3%
Value $13.44M Shares 94,796 Est. Cost $130.83 Unrealized +10.7%
ISRG Intuitive Surgical Inc 4.0%
Value $12.64M Shares 22,322 Est. Cost $542.50 Unrealized -1.9%
ONC BEONE MEDICINES LTD-ADR 3.9%
Value $12.28M Shares 40,432 Est. Cost $222.26 Unrealized
BBIO Bridgebio Pharma Inc 3.4%
Value $10.81M Shares 141,296 Est. Cost $31.34 Unrealized +109.5%
VRTX Vertex Pharmaceuticals Inc 3.3%
Value $10.42M Shares 22,984 Est. Cost $422.97 Unrealized +1.9%
BSX Boston Scientific Corp 3.3%
Value $10.36M Shares 108,682 Est. Cost $74.66 Unrealized +31.3%
SYK Stryker Corporation 3.0%
Value $9.432M Shares 26,835 Est. Cost $324.64 Unrealized +12.0%
CVS CVS HEALTH CORP 2.7%
Value $8.453M Shares 106,518 Est. Cost $78.67 Unrealized 0.0%
KRYS Krystal Biotech, Inc 2.7%
Value $8.346M Shares 33,853 Est. Cost $151.49 Unrealized +38.9%
COR Cencora Inc 2.6%
Value $8.029M Shares 23,773 Est. Cost $208.00 Unrealized +63.8%
IONS IONIS PHARMACEUTICALS INC 2.3%
Value $7.308M Shares 92,377 Est. Cost $75.30 Unrealized 0.0%
RVMD REVOLUTION Medicines Inc 2.3%
Value $7.183M Shares 90,184 Est. Cost $47.24 Unrealized +38.8%
AMGN Amgen Inc 2.3%
Value $7.169M Shares 21,903 Est. Cost $285.23 Unrealized +10.8%
MIRM Mirum Pharmaceuticals Inc 2.3%
Value $7.084M Shares 89,685 Est. Cost $36.30 Unrealized +97.7%
INCY INCYTE CORP 2.2%
Value $6.998M Shares 70,851 Est. Cost $96.76 Unrealized 0.0%
NAMS NewAmsterdam Pharma Co NV 2.2%
Value $6.912M Shares 197,036 Est. Cost $19.94 Unrealized +82.5%
ALKS Alkermes PLC 2.2%
Value $6.784M Shares 242,473 Est. Cost $26.70 Unrealized +12.2%
IRTC iRhythm Technologies Inc 2.1%
Value $6.668M Shares 37,579 Est. Cost $129.88 Unrealized +36.4%
GILD Gilead Sciences Inc 2.0%
Value $6.235M Shares 50,796 Est. Cost $101.28 Unrealized +19.4%
UFPT UFP Technologies Inc 1.6%
Value $5.104M Shares 22,986 Est. Cost $277.76 Unrealized -22.9%
INSM INSMED INC 1.5%
Value $4.851M Shares 27,873 Est. Cost $182.48 Unrealized 0.0%
CAH Cardinal Health Inc 1.5%
Value $4.823M Shares 23,470 Est. Cost $78.17 Unrealized +140.1%
ABVX ABIVAX SA 1.4%
Value $4.26M Shares 31,590 Est. Cost $134.85 Unrealized
CELC CELCUITY INC 1.3%
Value $4.172M Shares 41,831 Est. Cost $44.74 Unrealized +83.7%
IRON Disc medicine inc 1.2%
Value $3.809M Shares 47,967 Est. Cost $54.24 Unrealized +55.8%
IDYA IDEAYA BIOSCIENCES INC 1.1%
Value $3.368M Shares 97,438 Est. Cost $31.88 Unrealized 0.0%
UNH Universal Health Services Inc 1.0%
Value $3.191M Shares 14,636 Est. Cost $492.66 Unrealized -31.6%
CMPX COMPASS THERAPEUTICS INC 1.0%
Value $3.138M Shares 584,332 Est. Cost $4.62 Unrealized 0.0%
SLNO Soleno Therapeutics Inc 0.9%
Value $2.905M Shares 62,735 Est. Cost $58.22 Unrealized -5.8%
ACLX Arcellx Inc 0.9%
Value $2.72M Shares 41,717 Est. Cost $67.60 Unrealized +18.0%
DXCM Dexcom Inc 0.8%
Value $2.636M Shares 39,722 Est. Cost $97.28 Unrealized -33.5%
AUTL Autolus Therapeutics PLC 0.7%
Value $2.328M Shares 1,169,634 Est. Cost $2.89 Unrealized
BCAX BICARA THERAPEUTICS INC 0.6%
Value $1.874M Shares 111,363 Est. Cost $12.52 Unrealized +36.4%
CRBP Corbus Pharmaceuticals Holding 0.3%
Value $873K Shares 107,255 Est. Cost $20.42 Unrealized -39.6%
PYXS PYXIS ONCOLOGY INC 0.2%
Value $710K Shares 617,245 Est. Cost $3.53 Unrealized 0.0%